EUCRU Stock Price, Chart, Stats & News

Eucrates Biomedical Acquisition Corp.
Save
47.26M
Market cap
42.82x
Current P/E
–
Forward P/E
EUCRU chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -128.84% |
ROA | 44.36% |
ROE | 10.27% |
D/E | 0.01x |
Interest coverage ratio | – |
EUCRU valuation
P/E | 42.82x |
P/S | – |
P/B | 3.50x |
P/CF | -47.45x |
P/FCF | -67.00x |
P/OCF | -47.45x |
PEG | 0.05x |
EV multiple | -16.38x |
About
Eucrates Biomedical Acquisition Corp. currently possesses no substantial business activities. Its primary objective is to execute a business combination, which may involve a merger, an acquisition of shares or assets, or a reorganization, with one or more enterprises. The firm specifically aims to identify and acquire a target company within the biomedical or healthcare sectors across North America and Europe.
Similar securities
Based on sector and market capitalization
Report issue











